Financhill
Back

FlexShares Ultra-Short Income Fund Vs. NovoCure Industry Stock Comparison

Sell
26

RAVI
FlexShares Ultra-Short Income Fund

Last Price:
$75.21
Seasonality Move:
-0.12%
Sell
49

NVCR
NovoCure

Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
26
FlexShares Ultra-Short Income Fund (RAVI) is a Sell

Is FlexShares Ultra-Short Income Fund a Buy, Sell or Hold?

  • The current FlexShares Ultra-Short Income Fund [RAVI] share price is $75.21. The Score for RAVI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RAVI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.19. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RAVI Stock Price Chart

What is FlexShares Ultra-Short Income Fund's stock price today?

  • The FlexShares Ultra-Short Income Fund share price today is $75.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RAVI is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.19
    The current trend is moderately bullish and NVCR is experiencing slight selling pressure.

RAVI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 45.09 Sell
Chaikin Money Flow: 8997 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.16 - 75.38) Sell
Bollinger Bands (100): (75.28 - 75.52) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.94 Buy
Relative Strength Index (14 RSI): 58.79 Buy
Chaikin Money Flow: -60501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.36 - 32.64) Buy
Bollinger Bands (100): (14.38 - 25.86) Buy

RAVI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.14 Buy
20-day SMA: 75.25 Sell
50-day SMA: 75.34 Sell
200-day SMA: 75.36 Sell
8-day EMA: 75.19 Buy
20-day EMA: 75.24 Sell
50-day EMA: 75.31 Sell
200-day EMA: 75.32 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.52 Sell
20-day SMA: 30.41 Sell
50-day SMA: 23.25 Buy
200-day SMA: 18.89 Buy
8-day EMA: 30.36 Sell
20-day EMA: 29.22 Buy
50-day EMA: 25.18 Buy
200-day EMA: 21.21 Buy

FlexShares Ultra-Short Income Fund Earnings Growth & RAVI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

FlexShares Ultra-Short Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):